Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation

American Journal of Transplantation

Volumn 11, Issue 5, 2011, Pages 1064-1070

  De Vries, D K ^a   Lindeman, J H N ^a   Ringers, J ^a   Reinders, M E J ^a   Rabelink, T J ^a   Schaapherder, A F M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain death; cytokines; inflammation; ischemia; kidney transplantation; reperfusion

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; ARTERIAL BLOOD; ARTICLE; BRAIN DEATH; CADAVER KIDNEY; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; LIVING DONOR; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NEPHRITIS; PRIORITY JOURNAL; REPERFUSION INJURY; T LYMPHOCYTE; VENOUS BLOOD;

ADULT; AGED; BRAIN DEATH; CHEMOKINE CCL2; FEMALE; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; INTERLEUKIN-16; INTERLEUKIN-6; INTERLEUKIN-9; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGES; MALE; MIDDLE AGED; REPERFUSION; T-LYMPHOCYTES;

EID: 79955544128     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03466.x     Document Type: Article

References (20)

1. Roodnat JI, van R, I, Mulder PG, et al,. The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: A single-center, multivariate analysis. Transplantation 2003; 75: 2014-2018. (Pubitemid 36793284)
2. Pratschke J, Wilhelm MJ, Kusaka M, et al,. Accelerated rejection of renal allografts from brain-dead donors. Ann Surg 2000; 232: 263-271. (Pubitemid 30616728)
3. Schuurs TA, Gerbens F, Van Der Hoeven JA, et al,. Distinct transcriptional changes in donor kidneys upon brain death induction in rats: Insights in the processes of brain death. Am J Transplant 2004; 4: 1972-1981. (Pubitemid 39611624)
4. Nijboer WN, Schuurs TA, Van Der Hoeven JA, et al,. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004; 78: 978-986. (Pubitemid 39391858)
5. Nijboer WN, Schuurs TA, Van Der Hoeven JA, et al,. Effects of brain death on stress and inflammatory response in the human donor kidney. Transplant Proc 2005; 37: 367-369. (Pubitemid 40459788)
6. de Vries DK, Lindeman JH, Tsikas D, et al,. Early renal ischemia-reperfusion injury in humans is dominated by IL-6 release from the allograft. Am J Transplant 2009; 9: 1574-1584.
7. Stangl M, Zerkaulen T, Theodorakis J, et al,. Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 2001; 33: 1284-1285. (Pubitemid 32237847)
8. Schwarz C, Regele H, Steininger R, Hansmann C, Mayer G, Oberbauer R,. The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation 2001; 71: 1666-1670. (Pubitemid 32574170)
9. Jassem W, Koo DD, Muiesan P, et al,. Non-heart-beating versus cadaveric and living-donor livers: Differences in inflammatory markers before transplantation. Transplantation 2003; 75: 1386-1390. (Pubitemid 36513053)
10. Cugini D, Azzollini N, Gagliardini E, et al,. Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion. Kidney Int 2005; 67: 1753-1761. (Pubitemid 40577710)
11. Dubinski B, Boratynska M, Kopec W, Szyber P, Patrzalek D, Klinger M,. Activated cells in urine and monocyte chemotactic peptide-1 (MCP-1)-sensitive rejection markers in renal graft recipients. Transpl Immunol 2008; 18: 203-207. (Pubitemid 350151854)
12. Zweers N,. Donor brain death aggravates chronic rejection after lung transplantation in rats. Transplantation 2004; 78: 1251-1258. (Pubitemid 39507961)
13. Pratschke J, Wilhelm MJ, Laskowski I, et al,. Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 2001; 12: 2474-2481. (Pubitemid 33021126)
14. Araki M, Fahmy N, Zhou L, et al,. Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation 2006; 81: 783-788.
15. Wang S, Diao H, Guan Q, et al,. Decreased renal ischemia-reperfusion injury by IL-16 inactivation. Kidney Int 2008; 73: 318-326.
16. Furuichi K, Wada T, Iwata Y, et al,. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. Journal of the American Society of Nephrology 2003; 14: 2503-2515. (Pubitemid 37169336)
17. Kuecuek O, Mantouvalou L, Klemz R, et al,. Significant reduction of proinflammatory cytokines by treatment of the brain-dead donor. Transplant Proc 2005; 37: 387-388. (Pubitemid 40459796)
18. Kotsch K, Ulrich F, Reutzel-Selke A, et al,. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: A prospective randomized controlled trial. Ann Surg 2008; 248: 1042-1050.
19. Pratschke J, Kofla G, Wilhelm MJ, et al,. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor. Ann Surg 2001; 234: 732-740. (Pubitemid 33117193)
20. Gottmann U, Brinkkoetter PT, Hoeger S, et al,. Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: Possible role for aldose-reductase inhibition. Transplantation 2007; 84: 755-762. (Pubitemid 47480661)